Working… Menu
Trial record 4 of 7 for:    "Encephalitis" | "Pharmaceutical Solutions"

TBE Seropersistence up to 10 Years After First Booster in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01582698
Recruitment Status : Completed
First Posted : April 23, 2012
Last Update Posted : June 24, 2015
Information provided by (Responsible Party):
Baxter Healthcare Corporation

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015